Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Zhenkun Xia"'
Autor:
Ye Yao, Yu Yang, Ming Ji, Qingwu Qin, Kun Xu, Zhenkun Xia, Huijun Liu, Lin Yuan, Yunchang Yuan, Ling Qin, Xizi Du, Leyuan Wang, Kai Zhou, Xinyu Wu, Weijie Wang, Bei Qing, Yang Xiang, Xiangping Qu, Ming Yang, Xiaoqun Qin, Chi Liu
Publikováno v:
MedComm, Vol 5, Iss 7, Pp n/a-n/a (2024)
Abstract Acute asthma exacerbation refers to the progressive deterioration of asthma symptoms that is always triggered by virus infection represented by respiratory syncytial virus (RSV). After RSV infection, exaggerated Th2‐mediated pulmonary infl
Externí odkaz:
https://doaj.org/article/5c5acdb73e274cef95ac0f85cf8a7c2e
Autor:
Linguo Gu, Zhenkun Xia, Bei Qing, Wei Wang, Hongzuo Chen, Juan Wang, Ying Chen, Zhengling Gai, Rui Hu, Yunchang Yuan
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
ObjectiveTo examine the correlation between SIRI and the probability of cardiovascular mortality as well as all-cause mortality in individuals with chronic kidney disease.MethodsA cohort of 3,262 participants from the US National Health and Nutrition
Externí odkaz:
https://doaj.org/article/4a1e663961254441b00a34fcb1f01293
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-14 (2023)
Abstract To explore the clinical role of QPRT in breast cancer. The gene expression, methylation levels and prognostic value of QPRT in breast cancer was analyzed using TCGA data. Validation was performed using the data from GEO dataset and TNMPLOT d
Externí odkaz:
https://doaj.org/article/78cdf84cb3f345b28e4e52ca695f1330
Autor:
Hongzuo Chen, Zhenkun Xia, Bei Qing, Wei Wang, Linguo Gu, Ying Chen, Juan Wang, Yunchang Yuan
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundIPF is an undetermined, progressive lung disease. Necroptosis is a type of programmed apoptosis, which involved in the pathogenesis of lung diseases like COPD and ARDS. However, necroptosis in IPF have not been adequately studied. This stud
Externí odkaz:
https://doaj.org/article/e89c25d2b0eb4e07bc6c0bea4f53cf34
Publikováno v:
Thoracic Cancer, Vol 12, Iss 23, Pp 3088-3100 (2021)
Abstract Lung cancer is the leading cause of cancer‐related death worldwide due to diagnosis in the advanced stage and drug resistance in the subsequent treatments. Development of novel diagnostic and therapeutic methods is urged to improve the dis
Externí odkaz:
https://doaj.org/article/cabb4b3448564567bd7770b90d913ee9
Publikováno v:
Thoracic Cancer, Vol 12, Iss 9, Pp 1303-1311 (2021)
Abstract Background Esophageal squamous cell carcinoma (ESCC) is one of the deadliest malignancies. There is a growing body of evidence showing that long non‐coding RNAs (lncRNAs) play critical roles in ESCC oncogenesis. The present study aimed to
Externí odkaz:
https://doaj.org/article/8642fa53c3704b209913bfe47268e14d
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
ObjectiveTo further supplement the previous research on the relationship between neutrophil–lymphocyte ratio (NLR) and all-cause and cardiovascular mortality, and construct clinical models to predict mortality.MethodsA total number of 2,827 observe
Externí odkaz:
https://doaj.org/article/a084d57c35494ebaa7e6c339bec8d732
Autor:
Zhan Shi, Haohui Li, Wei Zhang, Youxiang Chen, Chunyan Zeng, Xiuhua Kang, Xinping Xu, Zhenkun Xia, Bei Qing, Yunchang Yuan, Guodong Song, Camila Caldana, Junyuan Hu, Lothar Willmitzer, Yan Li
Publikováno v:
Metabolites, Vol 12, Iss 12, p 1168 (2022)
As a comprehensive analysis of all metabolites in a biological system, metabolomics is being widely applied in various clinical/health areas for disease prediction, diagnosis, and prognosis. However, challenges remain in dealing with the metabolomic
Externí odkaz:
https://doaj.org/article/27ed5dacc8b049b7b5f5c3860c03fa61
Autor:
Xinfang Yu, Wei Li, Zhenkun Xia, Li Xie, Xiaolong Ma, Qi Liang, Lijun Liu, Jian Wang, Xinmin Zhou, Yifeng Yang, Haidan Liu
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-13 (2017)
Abstract Background Esophageal squamous cell carcinoma (ESCC) is one of the most lethal malignancies in China and is an exceptionally drug-resistant tumor with a 5-year survival rate less than 15%. Cisplatin is the most commonly used conventional che
Externí odkaz:
https://doaj.org/article/b307ef46469042afa7addf5f215851a4
Publikováno v:
Journal of Inflammation Research. 15:6187-6197
Xing Li,1â 3 Zexiang Zhu,3 Zhenkun Xia,4 Bo Xu1,2 1Department of Anesthesiology, The First Clinical College of Southern Medical University, Guangzhou, Peopleâs Republic of China; 2Department of Anesthesiology, General Hospital of the Southe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1406f4cd9fb5cb966ac08664f469a786
https://doi.org/10.2147/jir.s387613
https://doi.org/10.2147/jir.s387613